BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$126M
This Quarter Return
+16.15%
1 Year Return
+132.45%
3 Year Return
+197.53%
5 Year Return
–
10 Year Return
–
AUM
$248M
AUM Growth
+$248M
(+35%)
Cap. Flow
+$46.1M
Cap. Flow
% of AUM
18.6%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
11
New
2
Increased
3
Reduced
–
Closed
2
Top Buys
| 1 |
Twist Bioscience
TWST
|
$28.4M |
| 2 |
MaxCyte
MXCT
|
$21M |
| 3 |
Guardant Health
GH
|
$7.77M |
| 4 |
Natera
NTRA
|
$7.67M |
| 5 |
Adaptive Biotechnologies
ADPT
|
$3.42M |
Top Sells
| 1 |
Bruker
BRKR
|
$16.2M |
| 2 |
CareDx
CDNA
|
$5.92M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Guardant Health
GH
$8.41B
| $52.7M | 21.26% |
978,445
+144,300
| +17% | +$7.77M |
|
|
2
Natera
NTRA
$23.1B
| $48.4M | 19.54% |
1,104,581
+175,000
| +19% | +$7.67M |
|
3
Cytek Biosciences
CTKB
$527M
| $30.9M | 12.48% |
2,100,000
| – | – |
|
|
4
Twist Bioscience
TWST
$1.63B
| $28.4M | 11.45% |
+805,000
| New | +$28.4M |
|
|
5
Adaptive Biotechnologies
ADPT
$2.01B
| $25.6M | 10.35% |
3,600,434
+480,000
| +15% | +$3.42M |
|
|
AKYA
6
DELISTED
Akoya BioSciences
AKYA
| $24.7M | 9.98% |
2,104,785
| – | – |
|
|
7
MaxCyte
MXCT
$148M
| $21M | 8.46% |
+3,225,000
| New | +$21M |
|
8
Bio-Techne
TECH
$8.5B
| $13.2M | 5.33% |
46,500
| – | – |
|
|
SLGC
9
DELISTED
SomaLogic, Inc. Class A Common Stock
SLGC
| $2.88M | 1.16% |
992,086
| – | – |
|
|
10
Bruker
BRKR
$5.16B
| – | – |
-258,000
| Closed | -$16.2M |
|
|
11
CareDx
CDNA
$727M
| – | – |
-275,551
| Closed | -$5.92M |
|